Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Roche acquires innovatis for E15 million
innovatis will become a fully-integrated part of Roche Applied Science, a global business area of the diagnostic division of Roche. The company will continue to develop and market
innovatis will become a fully-integrated part of Roche Applied Science, a global business area of the diagnostic division of Roche. The company will continue to develop and market
pSivida, a drug delivery company, has reported encouraging interim 12-month safety and efficacy results from the first human pharmacokinetic study of Iluvien. The study is being conducted by
Sigma-Aldrich’s expansion of operations in Chile is part of the company’s strategic plan to accelerate growth in Canada, Asia Pacific and Latin America to 25% of corporate sales
In addition, NeoMatrix announced a current oversubscription of the C2 round totaling $1.2 million. In order to accommodate those investors who are part of this $1.2 million oversubscription
Astellas also intends to withdraw a related lawsuit in the Delaware Chancery Court against CV Therapeutics and its directors. Astellas said that it does not see value for
UK-based GW Pharmaceuticals has announced positive preliminary results from a pivotal Phase III double-blind randomized placebo-controlled study of Sativex in patients with spasticity due to multiple sclerosis, who
The Wilms tumor gene (WT1) biomarker is used in the prognosis and follow-up of normal karyotype acute myeloid leukemia (AML) patients, who account for nearly half of AML
Net loss for the 12-month period ended December 31, 2008 was $25.2 million or $1.88 per share, as compared to $13.7 million or $1.09 per share, for the
Dr Hamilton is a recognized expert in both the global development of topically active steroids as well as in graft-versus-host disease (GVHD) and has had a long and
The new US patent, which has 22 claims, includes assessment of heart rate in zebrafish and use of microplates for high-throughput screening. Patricia McGrath, president and CEO of